Join Optos at the 2014 World Ophthalmology Congress

The 2014 World Ophthalmology Congress (WOC2014) will take place in Tokyo, Japan this year from April 2-6. Considered by 200,000 ophthalmologists around the world as THE event to attend, WOC2014 will feature world-renowned speakers and exhibitors showcasing the latest devices and technology in the ophthalmic industry.

 

As Optos is at the cutting edge of technology with our optomap® Ultra-widefield retinal imaging (UWF) devices, we are thrilled to be exhibiting and speaking at this event! We would like to invite everyone attending the event to stop by our booth, E-52, or attend our seminar to learn more about our technology. At our booth, we will be showing our 200Tx, Daytona, 200Dx, OCT, OptosChart ELITE and AP300 devices.

 

The seminar will offer insight into the importance of and growing role of UWF imaging in modern ophthalmology. Several international speakers will be sharing their experience and research using the latest UWF retinal imaging technology. This lunch seminar will take place on Friday, April 4 at 12:15 pm in room 24 at Imperial Hotel.

 

304715_261868153930001_1803746157_n

Source: Facebook.com/WOC2014

 

Make plans now to join us at WOC2014! We look forward to meeting you there and sharing more information on our optomap® UWF retinal imaging devices with you.

 

Abstract

Optos is continuing to expand the clinical applications of optomap UWF. Studies demonstrate that significant clinical changes in diseases such as diabetic retinopathy, retinal vein occlusion, degenerative and inflammatory disease occur in the peripheral retina. Thus, the ability to image and monitor the entire retina with UWF imaging is crucially important. Additionally, targeted photocoagulation guided by UWF imaging may work together with pharmacological intervention to aid improved outcomes in Diabetic Macular Oedema. This symposium will educate delegates on the role of Optos technology to enable a new standard of care to be delivered that will lead to more effective detection and treatment of the retinal disease.